{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-007894","form_type":"8-K","ticker":"HRMY","cik":"0001802665","company_name":"Harmony Biosciences Holdings, Inc.","filed_at":"2025-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.775888+00:00","generated_at":"2026-05-21T05:30:34.910098+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"high","headline":"Harmony Biosciences shareholders re-elect three Class II directors and ratify auditor","bullets":["Elected Class II directors: Juan Sabater (25.9M for, 18.0M withheld), Gary Sender (35.0M for, 8.9M withheld), Linda Szyper (34.9M for, 9.0M withheld).","Ratified Deloitte & Touche as independent auditor for FY2025 with 44.7M for, 738.6K against, 17.1K abstain.","Total shares represented at meeting: 45,446,787, constituting a quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-007894","json":"https://secwatch.observer/filing/0001558370-25-007894.json","markdown":"https://secwatch.observer/filing/0001558370-25-007894.md","text":"https://secwatch.observer/filing/0001558370-25-007894.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802665/000155837025007894/0001558370-25-007894-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802665/000155837025007894/hrmy-20250515x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T05:30:34.910098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}